Quite a lot of smoke but very limited fire - The use of methamphetamine in Europe

Drug and Alcohol Review

Volumn 27, Issue 3, 2008, Pages 236-242

  Griffiths, Paul ^a   Mravcik, Viktor ^b   Lopez, Dominique ^a   Klempova, Danica ^a  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b Office of the Government of the Czech Republic   (Czech Republic)

Author keywords

Amphetamine; Czech Republic; Europe; Methamphetamine

Indexed keywords

CENTRAL STIMULANT AGENT; METHAMPHETAMINE; STREET DRUG;

ARTICLE; CRIME; DRUG ABUSE; EUROPE; HUMAN; PREVALENCE; RISK FACTOR; STATISTICS;

AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CRIME; EUROPE; HUMANS; METHAMPHETAMINE; PREVALENCE; RISK FACTORS; STREET DRUGS;

EID: 41549156121     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230801932588     Document Type: Article

References (42)

1. European Monitoring Center for Drugs and Drug Addiction (EMCDDA). Annual report 2007: the state of the drug problem in Europe. Luxembourg: EMCDDA, 2007.
2. EMCDDA Drug Profiles. Available at: http://www.emcdda.europa.eu/index. cfm?nnodeid=25328 (accessed 15 February 2008).
3. Zábranský T. Methamphetamine in the Czech Republic. J Drug Issues 2007;37:155-80.
4. Advisory Council on the misuse of drugs. Methylamphetamine review, technical report. Advisory council on the misuse of drugs, 2005.
5. Ulrich A. Hitler's drugged soldier in Spiegel online. Available at: http://www.spiegel.de/international/0,1518, 354606,00.html (accessed 15 February 2008).
6. Meyer U. Fritz Hauschild (1908-1974) and drug research in the 'German Democratic Republic' (GDR). Pharmazie 2005;60:468-72.
7. Ling TM, Davies LS. The use of methedrine in the diagnosis and treatment of the psychoneuroses. Am J Psychiatry 1952;109:38-9.
8. Lockett J. Hypotension following soluble thiopentone, and its prevention by the use of methedrine. Anaesthesia 1951;6:83-7.
9. Brussel JA, Wilson DC Jr, Shankel LW. The use of methedrine in psychiatric practice. Psychiatr Q 1954;28: 381-94.
10. Maclay DT. Methedrine (desoxyephedrine) in the treatment of neurosis: 25 cases. South Afr Med J 1953;27: 1061-3.
11. Shapiro H. Waiting for the man: the story of drugs and popular music. London: Quartet, 1988.
12. Hawks D, Mitcheson M, Ogbourne A, Edwards G. Abuse of methylamphetamine. BMJ 1969;2:715-21.
13. Advisory Committee on Drug Dependence (ACDD). The amphetamines and lysergic acid diethylamide 'LSD'. Report by the ACDD, 1970.
14. Ogata A. Constitution of ephedrine-desoxyephedrine. J Pharm Soc Jpn 1919;451:751-64.
15. Nožina M. (principal author). Drogová historie [Drug history]. Svět drog v Čechách [The world of drugs in Czechia], 1st edn. Praha & Orlik nad Vltavou: KLP-Koniasch Latin Press & Livingstone, 1997.
16. Mravčík V, Lejčková P, Korčiš ová B. Prevalenční odhady problémových uživatelů drog v České republice - souhrnný článek [Prevalence estimates of problem drug users in the Czech republic - summary], Adiktologie 2005;5:13-20.
17. Miovský M. Changing patterns of drug use in the Czech Republic during the post-communist era: a qualitative study. J Drug Issues 2007;37:73-102.
18. Ústav zdravotnických informací a statistiky ČR. Výběrové šetření o zdravotním stavu a životním stylu obyvatel České republiky zaměřené na zneužívání drog [Sample survey of the health status and life style of the population in the Czech Republic focused on drug abuse]. Praha: Ústav zdravotnických informací a statistiky ČR, 2006.
19. Csémy L, Lejčková P, Sadílek P, Sovinová H. Evropská školní studie o alkoholu a jiných drogách (ESPAD). Výsledky průzkumu v České republice v roce 2003 [ESPAD - results in the Czech Republic in 2003], Praha: Úřad vlády České republiky, 2006.
20. Vopravil J. Nelegální ekonomika v ČR 2003 [Czech illegal economy in 2003]. Praha: Český statistický úřad, 2005.
21. Petroš O, Mravčík V, Korčišová B. Spotřeba drog problémovými uživateli [Consumption of illicit drugs by problem users]. Adiktologie 2005;5:49-59.
22. Mravčík V, Lejčková P, Orlíková B, et al. Annual report - the Czech Republic 2005 drug situation. Prague: Office of the Government, 2006.
23. Zábranský T, Mravčík V, Korčiš ová B, Řehák V. Hepatitis C virus infection among injecting drug users in the Czech Republic-prevalence and associated factors. Eur Addict Res 2006;12:151-60.
24. Lejčková P, Mravčík V. Mortality of hospitalized drug users in the Czech Republic. J Drug Issues 2007;37: 103-18.
25. Kalina K. Developing the system of drug services in the Czech Republic. J Drug Issues 2007;37:181 -204.
26. Polanecký V, Studničková B, Klepetková M, Šeblová J, Zemanová R. Výroční zpráva ČR 2005 - Incidence, prevalence, zdravotní dopady a trendy léčených uživatelů drog [Annual report 2005 - incidence, prevalence, health consequences and trends of treated drug users]. Praha: Hygienická stanice hlavního města Prahy, 2006.
27. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). EMCDDA drug profiles. Methamphetamine. Available at: http://www.emcdda.europa.eu/index. cfm?fuseaction=public.Content&nnodeid=25480&sLanguageiso= EN (accessed 15 February 2008).
28. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2006: the state of the drug problem in Europe. Luxembourg: EMCDDA, 2006.
29. United Nations Office on Drugs and Crime (UNODC). 2007 World drug report. Vienna: UNODC, 2007. Available at: http://www.unodc.org/unodc/en/data-and- analysis/WDR. html (accessed 15 February 2008).
30. European Monitoring Centre for Drugs and Drug Addiction. Statistical Bulletin 2007, on line resource to access EMCDDA tables and graphs about the drug situation. Available at: http://www.emcdda.europa.eu/html.cfm/index34943EN. html (accessed 15 February 2008).
31. Forensic Science Service (UK), Forensic Intelligence Bureau: Drugs Intelligence Unit. Drugs Update, Issue 38, January-March 2007. UK: Forensic Science Service, 2008.
32. Slovak National Focal Point. Slovak Republic, new development, trends and in-depth information on selected issues. National Report to the EMCDDA, 2005. Available at http://www.emcdda.europa.eu/index.cfm?fuseaction= public.content&nNodelID=435 (accessed 15 February 2008).
33. Kubů P, Škařupová K, Csémy L. Tanec a drogy 2000 a 2003 [Dance and drugs 2000 and 2003]. Praha: Úřad vlády České republiky, 2006.
34. McCambridge J, Mitcheson L, Winstock A, Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 2005;100:1140-9.
35. Hickson F, Weatherburn P, Reid D, Jessup K, Hammond G. Consuming passions, findings from the UK Gay Men's sex survey 2005. UK: Sigma Research 2007. Available at: http://www.sigmaresearch.org.uk/downloads/report07c.pdf
36. Bolding G, Hart G, Sherr L, Elford J. Use of crystal methamphetamine among gay men in London. Addiction 2006;101:1622-30.
37. Bellis MA, Hughes K, Bennett A, Thomson R. The role of an international nightlife resort in the proliferation of recreational drugs. Addiction 2003;98:1713-21.
38. Griffiths P, Vingoe L, Hunt N, Mounteney J, Hartnoll R. Drug information system early warning and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption? Subst Use Misuse 2000;35:811-44.
39. Cadet-Taïrou A, Gandihlon M, Toufik A, Evrad I. Phé nomènes émergents liés aux drogues, 7ème rapport national du dispositif TREND. Saint-Denis: OFDT, 2007.
40. Boys A, Mardsen J. Perceived function predicts intensity of use and problems in young polysubstance users. Addiction 2003;98:951-63.
41. Boys A, Mardsen J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance abuse among young people: the relationship between perceived function and intentions. Addiction 1999;94:1043-50.
42. Schifano F, Corkery JM, Cuffolo G. Smokable and non smokable amphetamine type stimulants: clinical pharmacological and epidemiological issues with special reference to UK. Ann Ist Super Sanita 2007;43:110-15.